Skip to main content
Log in

Implantable devices to monitor patients with heart failure

  • Published:
Heart Failure Reviews Aims and scope Submit manuscript

Abstract

Reducing heart failure hospitalizations represents a major challenge for modern clinicians. Early detection of congestion plays a key role in disease management strategy. Apart from traditional methods (patient reporting symptoms, body weight monitoring), novel home-care strategies allow guided adjustments in medical therapy through telemonitoring embedded in cardiac electronic implantable devices or through stand-alone diagnostic devices for hemodynamic monitoring. Wireless pulmonary artery pressure monitoring seems to reduce re-admission risk and is currently approved for this purpose in patients with heart failure. Multiparameter monitoring is also appealing and could be a valuable tool in managing these patients. However, invasive techniques face several safety concerns and cost-effectiveness issues. Therefore, quest for future research and emerging technologies is necessary.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+
from €37.37 /Month
  • Starting from 10 chapters or articles per month
  • Access and download chapters and articles from more than 300k books and 2,500 journals
  • Cancel anytime
View plans

Buy Now

Price includes VAT (Netherlands)

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, de Ferranti S, Despres JP, Fullerton HJ, Howard VJ, Huffman MD, Judd SE, Kissela BM, Lackland DT, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Matchar DB, McGuire DK, Mohler ER 3rd, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Willey JZ, Woo D, Yeh RW, Turner MB (2015) Heart disease and stroke statistics--2015 update: a report from the American Heart Association. Circulation 131(4):e29–e322. https://doi.org/10.1161/cir.0000000000000152

    Article  Google Scholar 

  2. Ponikowski P, Voors AA, Anker SD, Bueno H, Cleland JG, Coats AJ, Falk V, Gonzalez-Juanatey JR, Harjola VP, Jankowska EA, Jessup M, Linde C, Nihoyannopoulos P, Parissis JT, Pieske B, Riley JP, Rosano GM, Ruilope LM, Ruschitzka F, Rutten FH, van der Meer P (2016) 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure: the task force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 18(8):891–975. https://doi.org/10.1002/ejhf.592

    Article  Google Scholar 

  3. Yancy CW, Jessup M, Bozkurt B, Butler J, Casey DE Jr, Colvin MM, Drazner MH, Filippatos G, Fonarow GC, Givertz MM, Hollenberg SM, Lindenfeld J, Masoudi FA, McBride PE, Peterson PN, Stevenson LW, Westlake C (2016) 2016 ACC/AHA/HFSA focused update on new pharmacological therapy for heart failure: an update of the 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America. Circulation 134(13):e282–e293. https://doi.org/10.1161/cir.0000000000000435

    Article  PubMed  Google Scholar 

  4. Brignole M, Auricchio A, Baron-Esquivias G, Bordachar P, Boriani G, Breithardt OA, Cleland J, Deharo JC, Delgado V, Elliott PM, Gorenek B, Israel CW, Leclercq C, Linde C, Mont L, Padeletti L, Sutton R, Vardas PE, Zamorano JL, Achenbach S, Baumgartner H, Bax JJ, Bueno H, Dean V, Deaton C, Erol C, Fagard R, Ferrari R, Hasdai D, Hoes AW, Kirchhof P, Knuuti J, Kolh P, Lancellotti P, Linhart A, Nihoyannopoulos P, Piepoli MF, Ponikowski P, Sirnes PA, Tamargo JL, Tendera M, Torbicki A, Wijns W, Windecker S, Kirchhof P, Blomstrom-Lundqvist C, Badano LP, Aliyev F, Bansch D, Baumgartner H, Bsata W, Buser P, Charron P, Daubert JC, Dobreanu D, Faerestrand S, Hasdai D, Hoes AW, Le Heuzey JY, Mavrakis H, McDonagh T, Merino JL, Nawar MM, Nielsen JC, Pieske B, Poposka L, Ruschitzka F, Tendera M, Van Gelder IC, Wilson CM (2013) 2013 ESC guidelines on cardiac pacing and cardiac resynchronization therapy: the task force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 34(29):2281–2329. https://doi.org/10.1093/eurheartj/eht150

    Article  PubMed  Google Scholar 

  5. Lip GY, Heinzel FR, Gaita F, Juanatey JR, Le Heuzey JY, Potpara T, Svendsen JH, Vos MA, Anker SD, Coats AJ, Haverkamp W, Manolis AS, Chung MK, Sanders P, Pieske B (2015) European Heart Rhythm Association/Heart Failure Association joint consensus document on arrhythmias in heart failure, endorsed by the Heart Rhythm Society and the Asia Pacific Heart Rhythm Society. Eur J Heart Fail 17(9):848–874. https://doi.org/10.1002/ejhf.338

    Article  PubMed  Google Scholar 

  6. Cleland JG, Swedberg K, Follath F, Komajda M, Cohen-Solal A, Aguilar JC, Dietz R, Gavazzi A, Hobbs R, Korewicki J, Madeira HC, Moiseyev VS, Preda I, van Gilst WH, Widimsky J, Freemantle N, Eastaugh J, Mason J (2003) The EuroHeart failure survey programme-- a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. Eur Heart J 24(5):442–463

    Article  CAS  Google Scholar 

  7. Stewart S (2005) Financial aspects of heart failure programs of care. Eur J Heart Fail 7(3):423–428. https://doi.org/10.1016/j.ejheart.2005.01.001

    Article  PubMed  Google Scholar 

  8. Setoguchi S, Stevenson LW, Schneeweiss S (2007) Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J 154(2):260–266. https://doi.org/10.1016/j.ahj.2007.01.041

    Article  PubMed  Google Scholar 

  9. Adamson PB (2009) Pathophysiology of the transition from chronic compensated and acute decompensated heart failure: new insights from continuous monitoring devices. Curr Heart Fail Rep 6(4):287–292

    Article  Google Scholar 

  10. Lewin J, Ledwidge M, O'Loughlin C, McNally C, McDonald K (2005) Clinical deterioration in established heart failure: what is the value of BNP and weight gain in aiding diagnosis? Eur J Heart Fail 7(6):953–957. https://doi.org/10.1016/j.ejheart.2005.06.003

    Article  CAS  PubMed  Google Scholar 

  11. Abraham WT, Compton S, Haas G, Foreman B, Canby RC, Fishel R, McRae S, Toledo GB, Sarkar S, Hettrick DA (2011) Intrathoracic impedance vs daily weight monitoring for predicting worsening heart failure events: results of the Fluid Accumulation Status Trial (FAST). Congest Heart Fail 17(2):51–55. https://doi.org/10.1111/j.1751-7133.2011.00220.x

    Article  PubMed  Google Scholar 

  12. Zile MR, Bennett TD, St John Sutton M, Cho YK, Adamson PB, Aaron MF, Aranda JM Jr, Abraham WT, Smart FW, Stevenson LW, Kueffer FJ, Bourge RC (2008) Transition from chronic compensated to acute decompensated heart failure: pathophysiological insights obtained from continuous monitoring of intracardiac pressures. Circulation 118(14):1433–1441. https://doi.org/10.1161/circulationaha.108.783910

    Article  PubMed  Google Scholar 

  13. Cleland JG, Antony R (2011) It makes SENSE to take a safer road. Eur Heart J 32(18):2225–2227. https://doi.org/10.1093/eurheartj/ehr120

    Article  PubMed  Google Scholar 

  14. Ferrante D, Varini S, Macchia A, Soifer S, Badra R, Nul D, Grancelli H, Doval H (2010) Long-term results after a telephone intervention in chronic heart failure: DIAL (randomized trial of phone intervention in chronic heart failure) follow-up. J Am Coll Cardiol 56(5):372–378. https://doi.org/10.1016/j.jacc.2010.03.049

    Article  PubMed  Google Scholar 

  15. Jaarsma T, van der Wal MH, Lesman-Leegte I, Luttik ML, Hogenhuis J, Veeger NJ, Sanderman R, Hoes AW, van Gilst WH, Lok DJ, Dunselman PH, Tijssen JG, Hillege HL, van Veldhuisen DJ (2008) Effect of moderate or intensive disease management program on outcome in patients with heart failure: coordinating study evaluating outcomes of advising and counseling in heart failure (COACH). Arch Intern Med 168(3):316–324. https://doi.org/10.1001/archinternmed.2007.83

    Article  Google Scholar 

  16. Cleland JG, Louis AA, Rigby AS, Janssens U, Balk AH (2005) Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) study. J Am Coll Cardiol 45(10):1654–1664. https://doi.org/10.1016/j.jacc.2005.01.050

    Article  PubMed  Google Scholar 

  17. Inglis SC, Clark RA, McAlister FA, Stewart S, Cleland JG (2011) Which components of heart failure programmes are effective? A systematic review and meta-analysis of the outcomes of structured telephone support or telemonitoring as the primary component of chronic heart failure management in 8323 patients: abridged Cochrane review. Eur J Heart Fail 13(9):1028–1040. https://doi.org/10.1093/eurjhf/hfr039

    Article  PubMed  Google Scholar 

  18. Chaudhry SI, Mattera JA, Curtis JP, Spertus JA, Herrin J, Lin Z, Phillips CO, Hodshon BV, Cooper LS, Krumholz HM (2010) Telemonitoring in patients with heart failure. N Engl J Med 363(24):2301–2309. https://doi.org/10.1056/NEJMoa1010029

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  19. Ong MK, Romano PS, Edgington S, Aronow HU, Auerbach AD, Black JT, De Marco T, Escarce JJ, Evangelista LS, Hanna B, Ganiats TG, Greenberg BH, Greenfield S, Kaplan SH, Kimchi A, Liu H, Lombardo D, Mangione CM, Sadeghi B, Sadeghi B, Sarrafzadeh M, Tong K, Fonarow GC (2016) Effectiveness of remote patient monitoring after discharge of hospitalized patients with heart failure: the better effectiveness after transition -- heart failure (BEAT-HF) randomized clinical trial. JAMA Intern Med 176(3):310–318. https://doi.org/10.1001/jamainternmed.2015.7712

    Article  PubMed  PubMed Central  Google Scholar 

  20. Abraham WT, Stough WG, Pina IL, Linde C, Borer JS, De Ferrari GM, Mehran R, Stein KM, Vincent A, Yadav JS, Anker SD, Zannad F (2014) Trials of implantable monitoring devices in heart failure: which design is optimal? Nat Rev Cardiol 11(10):576–585. https://doi.org/10.1038/nrcardio.2014.114

    Article  PubMed  Google Scholar 

  21. Reynolds DW, Bartelt N, Taepke R, Bennett TD (1995) Measurement of pulmonary artery diastolic pressure from the right ventricle. J Am Coll Cardiol 25(5):1176–1182

    Article  CAS  Google Scholar 

  22. Adamson PB, Magalski A, Braunschweig F, Bohm M, Reynolds D, Steinhaus D, Luby A, Linde C, Ryden L, Cremers B, Takle T, Bennett T (2003) Ongoing right ventricular hemodynamics in heart failure: clinical value of measurements derived from an implantable monitoring system. J Am Coll Cardiol 41(4):565–571

    Article  Google Scholar 

  23. Zile MR, Bourge RC, Bennett TD, Stevenson LW, Cho YK, Adamson PB, Aaron MF, Aranda JM Jr, Abraham WT, Smart FW, Kueffer FJ (2008) Application of implantable hemodynamic monitoring in the management of patients with diastolic heart failure: a subgroup analysis of the COMPASS-HF trial. J Card Fail 14(10):816–823. https://doi.org/10.1016/j.cardfail.2008.07.235

    Article  PubMed  Google Scholar 

  24. Bourge RC, Abraham WT, Adamson PB, Aaron MF, Aranda JM Jr, Magalski A, Zile MR, Smith AL, Smart FW, O'Shaughnessy MA, Jessup ML, Sparks B, Naftel DL, Stevenson LW (2008) Randomized controlled trial of an implantable continuous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol 51(11):1073–1079. https://doi.org/10.1016/j.jacc.2007.10.061

    Article  PubMed  Google Scholar 

  25. Abraham WT, Perl L (2017) Implantable hemodynamic monitoring for heart failure patients. J Am Coll Cardiol 70(3):389–398. https://doi.org/10.1016/j.jacc.2017.05.052

    Article  PubMed  Google Scholar 

  26. Stevenson LW, Zile M, Bennett TD, Kueffer FJ, Jessup ML, Adamson P, Abraham WT, Manda V, Bourge RC (2010) Chronic ambulatory intracardiac pressures and future heart failure events. Circ Heart Fail 3(5):580–587. https://doi.org/10.1161/circheartfailure.109.923300

    Article  PubMed  Google Scholar 

  27. Mooney DM, Fung E, Doshi RN, Shavelle DM (2015) Evolution from electrophysiologic to hemodynamic monitoring: the story of left atrial and pulmonary artery pressure monitors. Front Physiol 6:271. https://doi.org/10.3389/fphys.2015.00271

    Article  PubMed  PubMed Central  Google Scholar 

  28. Abraham WT, Adamson PB, Hasan A, Bourge RC, Pamboukian SV, Aaron MF, Raval NY (2011) Safety and accuracy of a wireless pulmonary artery pressure monitoring system in patients with heart failure. Am Heart J 161(3):558–566. https://doi.org/10.1016/j.ahj.2010.10.041

    Article  PubMed  Google Scholar 

  29. Adamson PB, Abraham WT, Aaron M, Aranda JM Jr, Bourge RC, Smith A, Stevenson LW, Bauman JG, Yadav JS (2011) CHAMPION trial rationale and design: the long-term safety and clinical efficacy of a wireless pulmonary artery pressure monitoring system. J Card Fail 17(1):3–10. https://doi.org/10.1016/j.cardfail.2010.08.002

    Article  PubMed  Google Scholar 

  30. Abraham WT, Adamson PB, Bourge RC, Aaron MF, Costanzo MR, Stevenson LW, Strickland W, Neelagaru S, Raval N, Krueger S, Weiner S, Shavelle D, Jeffries B, Yadav JS (2011) Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet 377(9766):658–666. https://doi.org/10.1016/s0140-6736(11)60101-3

    Article  PubMed  Google Scholar 

  31. Adamson PB, Abraham WT, Bourge RC, Costanzo MR, Hasan A, Yadav C, Henderson J, Cowart P, Stevenson LW (2014) Wireless pulmonary artery pressure monitoring guides management to reduce decompensation in heart failure with preserved ejection fraction. Circ Heart Fail 7(6):935–944. https://doi.org/10.1161/circheartfailure.113.001229

    Article  PubMed  Google Scholar 

  32. Heywood JT, Jermyn R, Shavelle D, Abraham WT, Bhimaraj A, Bhatt K, Sheikh F, Eichorn E, Lamba S, Bharmi R, Agarwal R, Kumar C, Stevenson LW (2017) Impact of practice-based management of pulmonary artery pressures in 2000 patients implanted with the CardioMEMS sensor. Circulation 135(16):1509–1517. https://doi.org/10.1161/circulationaha.116.026184

    Article  PubMed  Google Scholar 

  33. Desai AS, Bhimaraj A, Bharmi R, Jermyn R, Bhatt K, Shavelle D, Redfield MM, Hull R, Pelzel J, Davis K, Dalal N, Adamson PB, Heywood JT (2017) Ambulatory hemodynamic monitoring reduces heart failure hospitalizations in “real-world” clinical practice. J Am Coll Cardiol 69(19):2357–2365. https://doi.org/10.1016/j.jacc.2017.03.009

    Article  PubMed  Google Scholar 

  34. Vaduganathan M, DeFilippis EM, Fonarow GC, Butler J, Mehra MR (2017) Postmarketing adverse events related to the CardioMEMS HF system. JAMA Cardiol 2(11):1277–1279

    Article  Google Scholar 

  35. Schmier JK, Ong KL, Fonarow GC (2017) Cost-effectiveness of remote cardiac monitoring with the CardioMEMS heart failure system. Clin Cardiol 40(7):430–436. https://doi.org/10.1002/clc.22696

    Article  PubMed  Google Scholar 

  36. Anderson JL, Heidenreich PA, Barnett PG, Creager MA, Fonarow GC, Gibbons RJ, Halperin JL, Hlatky MA, Jacobs AK, Mark DB, Masoudi FA, Peterson ED, Shaw LJ (2014) ACC/AHA statement on cost/value methodology in clinical practice guidelines and performance measures: a report of the American College of Cardiology/American Heart Association Task Force on Performance Measures and Task Force on Practice Guidelines. J Am Coll Cardiol 63(21):2304–2322. https://doi.org/10.1016/j.jacc.2014.03.016

    Article  PubMed  Google Scholar 

  37. Forsberg SA (1971) Relations between pressure in pulmonary artery, left atrium, and left ventricle with special reference to events at end diastole. Br Heart J 33(4):494–499

    Article  CAS  Google Scholar 

  38. Hardaway RM 3rd (1982) Pulmonary artery pressure versus pulmonary capillary wedge pressure and central venous pressure in shock. Resuscitation 10(1):47–56

    Article  Google Scholar 

  39. Chaliki HP, Hurrell DG, Nishimura RA, Reinke RA, Appleton CP (2002) Pulmonary venous pressure: relationship to pulmonary artery, pulmonary wedge, and left atrial pressure in normal, lightly sedated dogs. Catheter Cardiovasc Interv 56(3):432–438. https://doi.org/10.1002/ccd.10203

    Article  PubMed  Google Scholar 

  40. Ritzema J, Melton IC, Richards AM, Crozier IG, Frampton C, Doughty RN, Whiting J, Kar S, Eigler N, Krum H, Abraham WT, Troughton RW (2007) Direct left atrial pressure monitoring in ambulatory heart failure patients: initial experience with a new permanent implantable device. Circulation 116(25):2952–2959. https://doi.org/10.1161/circulationaha.107.702191

    Article  PubMed  Google Scholar 

  41. Ritzema J, Troughton R, Melton I, Crozier I, Doughty R, Krum H, Walton A, Adamson P, Kar S, Shah PK, Richards M, Eigler NL, Whiting JS, Haas GJ, Heywood JT, Frampton CM, Abraham WT (2010) Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure. Circulation 121(9):1086–1095. https://doi.org/10.1161/circulationaha.108.800490

    Article  PubMed  Google Scholar 

  42. Maurer MS, Adamson PB, Costanzo MR, Eigler N, Gilbert J, Gold MR, Klapholz M, Saxon LA, Singh JP, Troughton R, Abraham WT (2015) Rationale and design of the left atrial pressure monitoring to optimize heart failure therapy study (LAPTOP-HF). J Card Fail 21(6):479–488. https://doi.org/10.1016/j.cardfail.2015.04.012

    Article  PubMed  Google Scholar 

  43. Abraham WT, Adamson PB, Costanzo MR, Eigler N, Gold M, Klapholz M, Maurer M, Saxon L, Singh J, Troughton R (2016) Hemodynamic monitoring in advanced heart failure: results from the LAPTOP-HF trial. J Card Fail 22(11):940. https://doi.org/10.1016/j.cardfail.2016.09.012

    Article  Google Scholar 

  44. Hubbert L, Baranowski J, Delshad B, Ahn H (2017) Left atrial pressure monitoring with an implantable wireless pressure sensor after implantation of a left ventricular assist device. ASAIO J 63(5):e60–e65. https://doi.org/10.1097/mat.0000000000000451

    Article  PubMed  PubMed Central  Google Scholar 

  45. Conraads VM, Tavazzi L, Santini M, Oliva F, Gerritse B, Yu CM, Cowie MR (2011) Sensitivity and positive predictive value of implantable intrathoracic impedance monitoring as a predictor of heart failure hospitalizations: the SENSE-HF trial. Eur Heart J 32(18):2266–2273. https://doi.org/10.1093/eurheartj/ehr050

    Article  PubMed  Google Scholar 

  46. van Veldhuisen DJ, Braunschweig F, Conraads V, Ford I, Cowie MR, Jondeau G, Kautzner J, Aguilera RM, Lunati M, Yu CM, Gerritse B, Borggrefe M (2011) Intrathoracic impedance monitoring, audible patient alerts, and outcome in patients with heart failure. Circulation 124(16):1719–1726. https://doi.org/10.1161/circulationaha.111.043042

    Article  PubMed  Google Scholar 

  47. Bhimaraj A (2013) Remote monitoring of heart failure patients. Methodist DeBakey Cardiovasc J 9(1):26–31

    Article  Google Scholar 

  48. Adamson PB, Gold MR, Bennett T, Bourge RC, Stevenson LW, Trupp R, Stromberg K, Wilkoff BL, Costanzo MR, Luby A, Aranda JM, Heywood JT, Baldwin HA, Aaron M, Smith A, Zile M (2011) Continuous hemodynamic monitoring in patients with mild to moderate heart failure: results of the reducing decompensation events utilizing intracardiac pressures in patients with chronic heart failure (REDUCEhf) trial. Congest Heart Fail 17(5):248–254. https://doi.org/10.1111/j.1751-7133.2011.00247.x

    Article  PubMed  Google Scholar 

  49. Brachmann J, Bohm M, Rybak K, Klein G, Butter C, Klemm H, Schomburg R, Siebermair J, Israel C, Sinha AM, Drexler H (2011) Fluid status monitoring with a wireless network to reduce cardiovascular-related hospitalizations and mortality in heart failure: rationale and design of the OptiLink HF study (optimization of heart failure management using OptiVol fluid status monitoring and CareLink). Eur J Heart Fail 13(7):796–804. https://doi.org/10.1093/eurjhf/hfr045

    Article  PubMed  PubMed Central  Google Scholar 

  50. Bohm M, Drexler H, Oswald H, Rybak K, Bosch R, Butter C, Klein G, Gerritse B, Monteiro J, Israel C, Bimmel D, Kaab S, Huegl B, Brachmann J (2016) Fluid status telemedicine alerts for heart failure: a randomized controlled trial. Eur Heart J 37(41):3154–3163. https://doi.org/10.1093/eurheartj/ehw099

    Article  PubMed  Google Scholar 

  51. Whellan DJ, Ousdigian KT, Al-Khatib SM, Pu W, Sarkar S, Porter CB, Pavri BB, O'Connor CM (2010) Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations: results from PARTNERS HF (program to access and review trending information and evaluate correlation to symptoms in patients with heart failure) study. J Am Coll Cardiol 55(17):1803–1810. https://doi.org/10.1016/j.jacc.2009.11.089

    Article  PubMed  Google Scholar 

  52. Landolina M, Perego GB, Lunati M, Curnis A, Guenzati G, Vicentini A, Parati G, Borghi G, Zanaboni P, Valsecchi S, Marzegalli M (2012) Remote monitoring reduces healthcare use and improves quality of care in heart failure patients with implantable defibrillators: the evolution of management strategies of heart failure patients with implantable defibrillators (EVOLVO) study. Circulation 125(24):2985–2992. https://doi.org/10.1161/circulationaha.111.088971

    Article  PubMed  Google Scholar 

  53. Arya A, Block M, Kautzner J, Lewalter T, Mortel H, Sack S, Schumacher B, Sogaard P, Taborsky M, Husser D, Hindricks G (2008) Influence of home monitoring on the clinical status of heart failure patients: design and rationale of the IN-TIME study. Eur J Heart Fail 10(11):1143–1148. https://doi.org/10.1016/j.ejheart.2008.08.004

    Article  PubMed  Google Scholar 

  54. Hindricks G, Taborsky M, Glikson M, Heinrich U, Schumacher B, Katz A, Brachmann J, Lewalter T, Goette A, Block M, Kautzner J, Sack S, Husser D, Piorkowski C, Sogaard P (2014) Implant-based multiparameter telemonitoring of patients with heart failure (IN-TIME): a randomised controlled trial. Lancet 384(9943):583–590. https://doi.org/10.1016/s0140-6736(14)61176-4

    Article  PubMed  Google Scholar 

  55. Morgan JM, Dimitrov BD, Gill J, Kitt S, Ng GA, McComb JM, Raftery J, Roderick P, Seed A, Williams SG, Witte KK, Wright DJ, Yao GL, Cowie MR (2014) Rationale and study design of the REM-HF study: remote management of heart failure using implanted devices and formalized follow-up procedures. Eur J Heart Fail 16(9):1039–1045. https://doi.org/10.1002/ejhf.149

    Article  PubMed  Google Scholar 

  56. Morgan JM, Kitt S, Gill J, McComb JM, Ng GA, Raftery J, Roderick P, Seed A, Williams SG, Witte KK, Wright DJ, Harris S, Cowie MR (2017) Remote management of heart failure using implantable electronic devices. Eur Heart J 38(30):2352–2360. https://doi.org/10.1093/eurheartj/ehx227

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nikolaos Karamichalakis.

Ethics declarations

Conflict of interest

Authors Nikolaos Karamichalakis, George Bakosis, Vasiliki Bistola, Ignatios Ikonomidis, and Antonios Sideris declare no conflict of interest. Author John Parissis has received horonaria for lectures from Servier, Novartis, and Roche diagnostics. Author Gerasimos Filippatos is committee member in trials sponsored by Novartis, Medtronic, Bayer, and Servier.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Karamichalakis, N., Parissis, J., Bakosis, G. et al. Implantable devices to monitor patients with heart failure. Heart Fail Rev 23, 849–857 (2018). https://doi.org/10.1007/s10741-018-9742-8

Download citation

  • Published:

  • Issue date:

  • DOI: https://doi.org/10.1007/s10741-018-9742-8

Keywords

Profiles

  1. Vasiliki Bistola